In previous experiments, we observed that SGSM2 had two-fold higher expression in tumours than in normal control tissues from Taiwanese BC patients, but the above statistical data strongly indicated that lower SGSM2 levels in BC patients could increase tumour recurrence. This evidence concerns the gene SGSM2 and breast cancer.